| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7389341 | Value in Health | 2017 | 9 Pages |
Abstract
iDet (bid) is the most cost-effective regimen, providing the highest QALY gain and NMB. iGlarg (od) and iDet (od) are possible options for those for whom the iDet (bid) regimen is not acceptable or does not achieve required glycemic control.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Dalia PhD, Elisabetta MSc, Bernard PhD, David MSc, Stephanie A. PhD,